These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21304113)

  • 1. Paliperidone-induced neuroleptic malignant syndrome.
    Nayak RB; Bhogale GS; Patil NM; Chate SS; Pandurangi AA; Shetageri VN
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E14-5. PubMed ID: 21304113
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible paliperidone-induced neuroleptic malignant syndrome: a case report.
    Özdemir A; Aksoy-Poyraz C; Kılıç-Yener E
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E22-3. PubMed ID: 23037666
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible neuroleptic malignant syndrome associated with paliperidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):477-8. PubMed ID: 18070861
    [No Abstract]   [Full Text] [Related]  

  • 5. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
    Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
    [No Abstract]   [Full Text] [Related]  

  • 7. Paliperidone-induced dystonic Dysphagia.
    Mendhekar DN; Agarwal A
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-v.e37-451.e37. PubMed ID: 21037154
    [No Abstract]   [Full Text] [Related]  

  • 8. Catatonia and encephalopathy associated with paliperidone palmitate.
    Coffey MJ
    J Clin Psychopharmacol; 2012 Apr; 32(2):284-5. PubMed ID: 22388156
    [No Abstract]   [Full Text] [Related]  

  • 9. Paliperidone-induced obsessive symptoms.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Liappas I
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E46. PubMed ID: 21677227
    [No Abstract]   [Full Text] [Related]  

  • 10. Paliperidone-induced tardive dystonia: a case report.
    Havaki-Kontaxaki B; Karaiskos D; Pappa D; Papadimitriou GN
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E51. PubMed ID: 23686064
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive Tourette-like syndrome in a patient treated with paliperidone.
    Fountoulakis KN; Panagiotidis P
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E35-6. PubMed ID: 22231343
    [No Abstract]   [Full Text] [Related]  

  • 12. Paliperidone-related Pisa syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):129-31. PubMed ID: 23288235
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible paliperidone-related pons infarction.
    Chang CC; Wang WF; Lai TJ
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E15-6. PubMed ID: 24515693
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.
    Langley-DeGroot M; Joshi Y; Lehman D; Rao S
    J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic induced catatonia: a case of probable dementia with Lewy bodies.
    Xiong GL; Palomino A; Kahn DR; Bourgeois JA
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):472-3. PubMed ID: 19996262
    [No Abstract]   [Full Text] [Related]  

  • 16. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786
    [No Abstract]   [Full Text] [Related]  

  • 17. Pisa syndrome induced by paliperidone.
    Pan PY; Chou HW; Cheng CC; Hsu YC; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E07-8. PubMed ID: 24515688
    [No Abstract]   [Full Text] [Related]  

  • 18. Manic symptoms during a switch from risperidone to paliperidone: a case report.
    Yang FW; Liang CS
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E29. PubMed ID: 21948917
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
    Guanci N; Aggarwal R; Schleifer S
    Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
    [No Abstract]   [Full Text] [Related]  

  • 20. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY; Chiu NY
    J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.